MDS-Device Aided Medical Therapy Module 1: A Practical Comparison of Apomorphine, Long-acting Dopamine Agonists, DBS and LCIG

Introduction

MDS-Device Aided Medical Therapy Module 1: A Practical Comparison of Apomorphine, Long-acting Dopamine Agonists, DBS and LCIG

Course Format

Webinar

Release Date

April 16, 2015

Expiration Date

June 01, 2025

Program Description

The MDS-Device Aided Medical Therapy Module 1 course will provide a practical comparison of apomorphine, long-acting dopamine agonists, DBS and LCIG. This module was reviewed for content and accuracy in June of 2020.

Faculty

Laura Silveira-Moriyama, MD, PhD - Universidade Estadual de Campinas, Campinas, Brazil

Thomas Foltynie, PhD, MRCP - National Hospital for Neurology, London, United Kingdom

Course Purpose

The primary purpose of this program is to provide information on comparisons of apomorphine, long-lasting dopamine agonists, DBS and LCIG.

Learning Objectives

Upon completion of this activity learners will be able to:

1. Describe how apomorphine, levodopa carbidopa, intestinal gel (LCIG), and deep brain stimulation (DBS) compare with each other and oral therapies

Intended Audience

This activity is intended for neurologists, neurosurgeons, specialist nurses, and other health professionals.

Hardware and Software Requirement

1. Active Internet connection (DSL or Cable). Dial-up connection will have constant buffering problem.

2. Compatible with Windows PC and MAC (256 MB of RAM or higher)

3. Activity is best viewed on Internet Explorer 9.0 or higher, Safari 5.0 or higher and Firefox 29.0 or higher

4. Adobe Flash Player 12.0 (or higher).

5. Adobe Reader to print certificate.

Contact Us

MDS Education
education@movementdisorders.org

MDS Secretariat Liaison

Ericka Blackford